EMEA (Europe, Middle East and Africa) Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

December 2017 | 112 pages | ID: E25FBDCDE94EN
QYResearch

Abstracts

In this report, the EMEA Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Aslan Pharmaceuticals Pte Ltd
• Boehringer Ingelheim GmbH
• GamaMabs Pharma SA
• Hanmi Pharmaceuticals Co Ltd
• Jiangsu Kanion Pharmaceutical Co Ltd
• Minerva Neurosciences Inc
• Pfizer Inc
• Puma Biotechnology Inc
• Shanghai Fosun Pharmaceutical (Group) Co Ltd
• XuanZhu Pharma Co Ltd
• Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Afatinib Dimaleate
• Dacomitinib
• Neratinib
• Neucardin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Cardiovascular
• Central Nervous System
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

1 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS OVERVIEW

1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs
  1.2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Afatinib Dimaleate
  1.2.4 Dacomitinib
  1.2.5 Neratinib
  1.2.6 Neucardin
  1.2.7 Others
1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
  1.3.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Cardiovascular
  1.3.4 Central Nervous System
  1.3.5 Others
1.4 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
  1.4.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
  1.5.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 EMEA RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Players (2012-2017)
2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Type (2012-2017)
2.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume) by Application
2.4 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs (Volume and Value) by Region
  2.4.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price by Region (2012-2017)

3 EUROPE RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
  3.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
3.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
3.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
4.3 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
4.4 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

5 AFRICA RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Value (2012-2017)
  5.1.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type
5.3 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application
5.4 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2017)

6 EMEA RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Aslan Pharmaceuticals Pte Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim GmbH
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GamaMabs Pharma SA
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hanmi Pharmaceuticals Co Ltd
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Jiangsu Kanion Pharmaceutical Co Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Minerva Neurosciences Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Puma Biotechnology Inc
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 XuanZhu Pharma Co Ltd
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Zensun (Shanghai) Sci & Tech Co Ltd

7 RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MANUFACTURING COST ANALYSIS

7.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RECEPTOR TYROSINE PROTEIN KINASE TARGETED DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Afatinib Dimaleate Product Picture
Figure Dacomitinib Product Picture
Figure Neratinib Product Picture
Figure Neucardin Product Picture
Figure Others Product Picture
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Central Nervous System Examples
Table Key Downstream Customer in Central Nervous System
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players (2012-2017)
Figure 2016 Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players
Figure 2017 Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Players
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players
Table 2017 EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Players
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type (2012-2017)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Type in 2016
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Application (2012-2017)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2016
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Region (2012-2017)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in 2016
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Receptor Tyrosine Protein Kinase Targeted Drugs by Region (2012-2017)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Regions in 2016
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2017)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type in 2016
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Application in 2016
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries in 2016
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2016
Figure Germany Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Type (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Applications (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application in 2016
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2016
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Countries in 2016
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries in 2016
Figure South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in EMEA (2012-2017)
Figure XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share in EMEA (2012-2017)
Table Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
Figure Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
Table Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
Table Major Buyers of Receptor Tyrosine Protein Kinase Targeted Drugs
Table Distributors/Traders List
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources